Pathway of apoptosis induced in Jurkat T lymphoblasts by anti-HLA class I antibodies

Human Immunology

Volumn 65, Issue 3, 2004, Pages 189-199

  Daniel, Dinara ^a   Opelz, Gerhard ^a   Mulder, Arend ^b   Kleist, Christian ^a   Süsal, Caner ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

AIF; Anti HLA antibodies; Apoptosis; Caspases; DNA fragmentation

Indexed keywords

APOPTOSIS INDUCING FACTOR; BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CYTOCHROME C; DNA FRAGMENT; HLA ANTIBODY; HLA ANTIGEN CLASS 1; MONOCLONAL ANTIBODY;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DNA CLEAVAGE; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; REACTION TIME; SIGNAL TRANSDUCTION; T LYMPHOBLAST;

ANIMALS; APOPTOSIS; CASPASE 3; CASPASES; DNA FRAGMENTATION; ENZYME INHIBITORS; HLA ANTIGENS; HUMANS; JURKAT CELLS; MEMBRANE POTENTIALS; MICE; MITOCHONDRIA; SIGNAL TRANSDUCTION;

EID: 1642415890     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2003.12.003     Document Type: Article

References (31)

1. Pettersen R.D., Hestdal K., Lie S.O., Gaudernack G. Role of the TCR binding region of the HLA class I alpha 2 domain in regulation of cell adhesion and proliferation. J Immunol. 156:1996;1415.
2. Smith D.M., Bluestone J.A., Jeyarajah D.R., Newberg M.H., Engelhard V.H., Thistlethwaite J.R., Woodle E.S. Inhibition of T cell activation by a monoclonal antibody reactive against the alpha 3 domain of human MHC class I molecules. J Immunol. 153:1994;1054.
3. 2-terminal kinase activity: a novel apoptotic pathway distinct from Fas-induced apoptosis. J Cell Biol. 139:1997;1523.
4. Daniel D., Opelz G., Mulder A., Süsal C. Induction of apoptosis in human lymphocytes by human anti-HLA class I antibodies. Transplantation. 75:2003;1380.
5. Woodle S.E., Smith D.M., Bluestone J.A., Kirkman W.M., Green D.R., Skowronski E.W. Anti-human class I MHC antibodies induce apoptosis by a pathway that is distinct from the Fas antigen-mediated pathway. J Immunol. 158:1997;2156.
6. Budijardjo I., Oliver H., Lutter M., Luo X., Wang X. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol. 15:1999;269.
7. Liu X., Zou H., Slaughter C., Wang X. DFF, a heterodimeric protein that functions downstream of caspase 3 to trigger DNA fragmentation during apoptosis. Cell. 89:1997;175.
8. Ruefli A.A., Smyth M.J., Johnstone R.W. HMBA induces activation of a caspase-independent cell death pathway to overcome P-glycoprotein-mediated multidrug resistance. Blood. 95:2000;2378.
9. Du C., Fang M., Li Y., Li L., Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell. 102:2000;33.
10. Daugas E., Susin S.A., Zamzami N., Ferri K.F., Irinopoulou T., Larochette N., Prevost M.C., Leber B., Andrews D., Penninger J., Kroemer G. Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB J. 14:2000;729.
11. Susin S.A., Lorenzo H.K., Zamzami N., Marzo I., Snow B.E., Brothers G.M., Mangion J., Jacotot E., Costantini P., Loeffler M., Larochette N., Goodlett D.R., Aebersold R., Siderovski D.P., Penninger J.M., Kroemer G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature. 397:1999;441.
12. 2 domain signals rapid Fas-independent cell death: a direct pathway for T cell-mediated killing of target cells? J Immunol. 160:1998;4343.
13. Armstrong R.C., Aja T., Xiang J., Gaur S., Krebs J.F., Hoang K., Bai X., Korsmeyer S.J., Karanewsky D.S., Fritz L.C., Tomaselli K.J. Fas-induced activation of the cell death-related protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors. J Biol Chem. 271:1996;16850.
14. Kaioumova D., Süsal C., Opelz G. Induction of apoptosis in human lymphocytes by the herbicide 2,4-dichlorophenoxyacetic acid. Human Immunol. 62:2001;64.
15. Nunez G., Benedict M.A., Hu Y., Inohara N. Caspases: the proteases of the apoptotic pathway. Oncogene. 17:1998;3237.
16. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., Peng T.I., Jones D.P., Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 275:1997;1129.
17. Klaus S.J., Sidorenko S.P., Clark E.A. CD45 ligation induces programmed cell death in T and B lymphocytes. J Immunol. 156:1996;2743.
18. Bossy-Wetzel E., Newmeyer D.D., Green D.R. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J. 17:1998;37.
19. Brown D.G., Sun X.-M., Cohen G.M. Dexamethasone-induced apoptosis involves cleavage of DNA to large fragments prior to internucleosomal fragmentation. J Biol Chem. 268:1993;3037.
20. Fulda S., Scaffidi C., Susin S.A., Krammer P.H., Kroemer G., Peter M.E., Debatin K.M. Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. J Biol Chem. 273:1998;33942.
21. Truman J.P., Ericson M.L., Choqueux-Seebold C.J., Charron D.J., Mooney N.A. Lymphocyte programmed cell death is mediated via HLA class II DR. Int Immunol. 6:1994;887.
22. Drenou B., Blancheteau V., Burgess D.H., Fauchet R., Charron D.J., Mooney N.A. A caspase-independent pathway of MHC class II antigen-mediated apoptosis of human B lymphocytes. J Immunol. 163:1999;4115.
23. Nagy Z.A., Hubner B., Lohning C., Rauchenberger R., Reiffert S., Thomassen-Wolf E., Zahn S., Leyer S., Schier E.M., Zahradnik A., Brunner C., Lobenwein K., Rattel B., Stanglmaier M., Hallek M., Wing M., Anderson S., Dunn M., Kretzschmar T., Tesar M. Fully human, HLA-DR-specific monoclonal antibodies efficiently induce programmed death of malignant lymphoid cells. Nat Med. 8:2002;801.
24. Newell M.K., VanderWall J., Beard K.S., Freed J.H. Ligation of major histocompatibility complex class II molecules mediates apoptotic cell death in resting B lymphocytes. Proc Natl Acad Sci USA. 90:1993;10459.
25. Ferri K.F., Jacotot E., Blanco J., Este J.A., Zamzami N., Susin S.A., Xie Z., Brothers G., Reed J.C., Penninger J.M., Kroemer G. Apoptosis control in syncytia induced by the HIV type 1-envelope glycoprotein complex: role of mitochondria and caspases. J Exp Med. 192:2000;1081.
26. L inhibits ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis. Cancer Res. 57:1997;3115.
27. Trbovich A.M., Hughes F.M. Jr, Perez G.I., Kugu K., Tilly K.I., Cidlowski J.A., Tilly J.L. High and low molecular weight DNA cleavage in ovarian granulosa cells: characterization and protease modulation in intact cells and in cell-free nuclear autodigestion assays. Cell Death Differ. 5:1998;38.
28. Samejima K., Tone S., Kottke T.J., Enari M., Sakahira H., Cooke C.A., Durrieu F., Martins L.M., Nagata S., Kaufmann S.H., Earnshaw W.C. Transition from caspase-dependent to caspase-independent mechanisms at the onset of apoptotic execution. J Cell Biol. 143:1998;225.
29. Johnstone R.W., Cretney E., Smyth M.J. P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death. Blood. 93:1999;1075.
30. Sette A., Chesnut R., Fikes J. HLA expression in cancer: implications for T cell-based immunotherapy. Immunogenetics. 53:2001;255.
31. Rees R., Mian S. Selective MHC expression in tumours modulates adaptive and innate antitumour responses. Cancer Immunol Immunother. 48:1999;374.